HeartSciences Inc.
HSCSW- Exchange
- Nasdaq
- Industry
- Finance Services
- SEC CIK
- 0001468492
No open-market purchases or sales by HeartSciences Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $23.2K in total; no superinvestor holds it.
Other share classesHSCS
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 3
- 13F valueReported value at the end of Q2 2026
- $23.2K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding HSCSW, Q2 2026
No superinvestor reported holding HSCSW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by HeartSciences Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2025 (view filing) | Jul 29 | 1 day | Hilz Mark TCOO, Secretary and Director | SSaleCommon Stock, $0.001 par value | −4.42K | $3.54 | −$15.6K | −48.2%4.75K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in HeartSciences Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clear Street Group Inc. | 270,770 | $13.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 187,495 | $9.56K | 0.00% | −5,092−2.6% | Reduced |
| UBS Group AG | 1,086 | $54 | 0.00% | 00.0% | Unchanged |